Published in Clin Exp Immunol on December 01, 1993
Q fever. Clin Microbiol Rev (1999) 11.32
Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. Int J Microbiol (2011) 1.33
Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis. Infect Immun (1996) 1.30
Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect Immun (2004) 1.21
Production of interleukin-10 and transforming growth factor beta by peripheral blood mononuclear cells in Q fever endocarditis. Infect Immun (1996) 1.18
Interleukin-10 stimulates Coxiella burnetii replication in human monocytes through tumor necrosis factor down-modulation: role in microbicidal defect of Q fever. Infect Immun (2001) 1.06
The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis. PLoS Pathog (2008) 1.06
Circulating cytokine balance and activation markers of leucocytes in Q fever. Clin Exp Immunol (1999) 1.03
Role for the CD28 molecule in the control of Coxiella burnetii infection. Infect Immun (2006) 0.96
From Q Fever to Coxiella burnetii Infection: a Paradigm Change. Clin Microbiol Rev (2017) 0.93
alpha(v)beta(3) integrin and bacterial lipopolysaccharide are involved in Coxiella burnetii-stimulated production of tumor necrosis factor by human monocytes. Infect Immun (2000) 0.91
Coxiella burnetii survives in monocytes from patients with Q fever endocarditis: involvement of tumor necrosis factor. Infect Immun (2000) 0.89
Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus. Nat Rev Endocrinol (2010) 0.85
Long-Term immune responses to Coxiella burnetii after vaccination. Clin Vaccine Immunol (2012) 0.84
Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice. Diagn Microbiol Infect Dis (2014) 0.78
The effect of C. burnetii infection on the cytokine response of PBMCs from pregnant goats. PLoS One (2014) 0.77
The 75-kD tumour necrosis factor (TNF) receptor is specifically up-regulated in monocytes during Q fever endocarditis. Clin Exp Immunol (2000) 0.77
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med (1989) 11.36
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med (1988) 7.02
The isolation and characterization of the human suppressor inducer T cell subset. J Immunol (1985) 6.69
Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol (1989) 5.92
India ink staining of proteins on nitrocellulose paper. Anal Biochem (1983) 5.78
SDS microslab linear gradient polyacrylamide gel electrophoresis. Anal Biochem (1978) 5.04
Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today (1992) 4.63
Human TH1 and TH2 subsets: doubt no more. Immunol Today (1991) 3.81
A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods (1987) 3.56
Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med (1991) 3.41
Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev (1989) 3.21
Lipopolysaccharide antagonists. Immunol Today (1992) 2.37
A new view of prostaglandin E regulation of the immune response. Immunol Today (1991) 2.36
Prostaglandin E inhibits the production of human interleukin 2. J Exp Med (1982) 2.34
Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol (1989) 1.66
Protective or neutralizing antibody in Q fever. Am J Hyg (1957) 1.58
Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation. Infect Immun (1975) 1.55
Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun (1986) 1.47
Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins. J Immunol (1979) 1.45
Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts. Infect Immun (1984) 1.38
Experimental Q fever infection in congenitally athymic nude mice. Infect Immun (1978) 1.34
Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs. Epidemiol Infect (1990) 1.28
Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans. J Infect Dis (1983) 1.26
Study on the effect of cyclophosphamide on experimental rickettsial infection. Acta Virol (1971) 1.26
Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine. J Infect Dis (1988) 1.23
Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens. Infect Immun (1989) 1.17
Cellular immunity in Q fever: specific lymphocyte unresponsiveness in Q fever endocarditis. J Infect Dis (1985) 1.10
Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet (1987) 1.09
Engagement of CD14 on human monocytes terminates T cell proliferation by delivering a negative signal to T cells. J Immunol (1991) 0.94
Comparison of monocyte separation methods using flow cytometric analysis. J Immunol Methods (1989) 0.92
Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens. Clin Exp Immunol (1991) 0.91
Immunologic effects of nonsteroidal anti-inflammatory agents. Med Clin North Am (1985) 0.79
Cell-mediated immune response to Coxiella burnetii antigens in Q fever convalescents and vaccinees. Acta Virol (1989) 0.77
Immunochemical analysis of Mycoplasma pneumoniae. 3. Separation and chemical identification of serologically active lipids. Aust J Exp Biol Med Sci (1969) 2.73
Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med (1998) 2.45
Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever. J Med Microbiol (1985) 1.72
Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM (1998) 1.69
Vaccine prophylaxis of abattoir-associated Q fever. Lancet (1984) 1.55
Laboratory diagnosis of Mycoplasma pneumoniae infection. 1. Direct detection of antigen in respiratory exudates by enzyme immunoassay. Epidemiol Infect (1988) 1.52
Laboratory diagnosis of Mycoplasma pneumoniae infection. 2. Comparison of methods for the direct detection of specific antigen or nucleic acid sequences in respiratory exudates. Epidemiol Infect (1988) 1.48
Immunochemical analysis of Mycoplasma pneumoniae. 1. Methods of extraction and reaction of fractions from M. pneumoniae and from M. mycoides with homologous antisera and with antisera against Streptococcus MG. Aust J Exp Biol Med Sci (1967) 1.46
Immunochemical analysis of Mycoplasma pneumoniae. Ann N Y Acad Sci (1967) 1.45
Post-infection fatigue syndrome following Q fever. QJM (1998) 1.38
Control of hepatitis in dialysis units. Br Med Bull (1972) 1.38
Carbohydrates in hepatitis B antigen. Nat New Biol (1973) 1.30
Long-term persistence of Coxiella burnetii in the host after primary Q fever. Epidemiol Infect (2000) 1.29
Prevalence of antibody to hepatitits B surface antigen among staff in an Edinburgh hospital. J Hyg (Lond) (1977) 1.28
Laboratory diagnosis of Mycoplasma pneumoniae infection. 4. Antigen capture and PCR-gene amplification for detection of the Mycoplasma: problems of clinical correlation. Epidemiol Infect (1992) 1.24
Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine. J Infect Dis (1988) 1.23
Cytology of rheumatoid synovial cells in culture. I. Composition and sequence of cell populations in cultures of rheumatoid synovial fluid. Ann Rheum Dis (1974) 1.21
Cytoplasmic (but not nuclear) hepatitis B virus (HBV) core antigen reflects HBV DNA synthesis at the level of the infected hepatocyte. Intervirology (1985) 1.21
Protracted debility and fatigue after acute Q fever. Lancet (1996) 1.13
Attempts to identify viruses in rheumatoid synovial cells. Ann Rheum Dis (1976) 1.10
A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs. Epidemiol Infect (1990) 1.08
Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization. Hepatology (1984) 1.07
Patterns of single- and double-stranded hepatitis B virus DNA and viral antigen accumulation in infected liver cells. J Gen Virol (1983) 1.06
Mycoplasmas and rheumatoid arthritis. Ann Rheum Dis (1974) 1.04
Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child (1984) 1.03
Immunochemical analysis of Mycoplasma pneumoniae. 2. Properties of chloroform-methanol extract from M. pneumoniae. Aust J Exp Biol Med Sci (1968) 1.01
Rubella virus and rheumatoid arthritis. Ann Rheum Dis (1977) 1.01
Related antigens in Mycoplasma pneumoniae and Mycoplasma mycoides var. mycoides. Aust J Exp Biol Med Sci (1965) 1.01
Laboratory diagnosis of Mycoplasma pneumoniae infection. 3. Detection of IgM antibodies to M. pneumoniae by a modified indirect haemagglutination test. Epidemiol Infect (1989) 1.00
Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med J Aust (1994) 0.98
Rheumatoid polyarthritis after rubella. Ann Rheum Dis (1978) 0.98
High levels of cytoplasmic hepatitis B core antigen as reliable marker of HBV DNA replication. Lancet (1985) 0.98
Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens. QJM (2010) 0.97
Chronic cryptic Q-fever infection of the heart. Lancet (1979) 0.97
Dialysis-associated hepatitis in Edinburgh; 1969-1978. Rev Infect Dis (1982) 0.95
Confirmation of fatal Mycoplasma pneumoniae infection by polymerase chain reaction detection of the adhesin gene in fixed lung tissue. J Infect Dis (1994) 0.94
Binding of microorganisms to the macrophage plasma membrane; effects of enzymes and periodate. Br J Exp Pathol (1978) 0.94
Cytology of rheumatoid synovial cells in culture. II. Association of polykarocytes with rheumatoid and other forms of arthritis. Ann Rheum Dis (1974) 0.93
Cytology of rheumatoid synovial cells in culture. III. Significance of isolates of epithelial cell lines. Ann Rheum Dis (1974) 0.92
Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens. Clin Exp Immunol (1991) 0.91
Sexually transmitted Q fever. Clin Infect Dis (2001) 0.90
Development of Q-fever vaccines, 1937 to 1967. Med J Aust (1967) 0.89
Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue. Hepatology (1986) 0.89
DNA polymerase activity in rheumatoid synovial membranes. Ann Rheum Dis (1975) 0.88
Aetiology of rheumatoid arthritis: an attempt to transmit an infective agent from patients with rheumatoid arthritis to baboons. Ann Rheum Dis (1983) 0.87
The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum. Br J Cancer (1975) 0.87
Tryptic cleavage of antibody binding sites from hepatitis B surface antigen particles. J Gen Virol (1976) 0.85
Detection of hepatitis B virus DNA sequences in infected hepatocytes by in situ cytohybridisation. J Med Virol (1981) 0.83
Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever. QJM (2005) 0.83
Eaton agent--science and scientific acceptance: a historical commentary. Rev Infect Dis (1990) 0.82
Co-cultivation of human cell lines with synovial fluids of patients with rheumatoid arthritis. Rheumatology (1975) 0.82
Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome. Genes Immun (2003) 0.80
Production of a monoclonal antibody to human interferon-alpha (IFN-alpha) and its use to identify IFN-alpha-producing cells in virus infection in vivo. Microb Pathog (1986) 0.80
Viruses and lymphocytes in rheumatoid arthritis. I. Studies on cultured rheumatoid lymphocytes. Ann Rheum Dis (1979) 0.80
Rheumatoid arthritis, rheumatoid factor, and tests for Australia or hepatitis-associated antigen. Br Med J (1972) 0.80
Growth factors for Mycoplasma pneumoniae in yeast and tissue extracts. J Appl Bacteriol (1979) 0.78
Cell culture and infectious hepatitis. Med J Aust (1966) 0.75
Q fever: still a mysterious disease. QJM (2002) 0.75
Q fever trilogy morbidity--deadends--stark choices. Aust N Z J Public Health (1997) 0.75
Enhanced amplification of hepatitis C virus (HCV) cDNA by PCR: detection of HCV RNA in archival sera. J Clin Microbiol (1996) 0.75
Viruses and lymphocytes in rheumatoid arthritis. II. Examination of lymphocytes and sera from patients with rheumatoid arthritis for evidence of retrovirus infection. Ann Rheum Dis (1979) 0.75
Cytology of rheumatoid synovial cells in culture. IV. Further investigations of cell lines cocultivated with rheumatoid synovial cells. Ann Rheum Dis (1976) 0.75
Infective hepatitis and the handling of specimens in general practice. J R Coll Gen Pract (1971) 0.75
Prevalence of antibody to hepatitis B antigen among hospital personnel. Health Bull (Edinb) (1976) 0.75
Prospects for new viral vaccines. Philos Trans R Soc Lond B Biol Sci (1980) 0.75
An integrated final undergraduate examination. Br J Med Educ (1967) 0.75
Q fever. Med J Aust (1980) 0.75
The Applications of Fluorescent Antibody Techniques in Bacteriology and Virology. Proc R Soc Med (1963) 0.75